Pharma Logistics IQ launches the Pharma Anti-Counterfeiting & Supply Chain Security Online Summit

Is your biopharma supply chain secure?

Pharma IQ

London, UK - Pharma Logistics IQ, a leading hub for pharmaceutical supply chain professionals, has launched the Anti-Counterfeiting and Supply Chain Security Online Summit. It will run from 3rd-5th September 2019.

Over seven complimentary webinar sessions, experts will share case studies and personal insight on how to manage regulatory changes in the industry, improve supply chain security and test new anti-counterfeiting tech.

Our headline session focuses on Russia’s upcoming 2020 serialization requirements. With only 3 months from the summit until the regulation comes into effect, this session will help supply chain leaders to prepare and act.

We’ll also be bringing in experts from the fast moving consumer goods (FMCG) industry to share tactics from decades of experience in battling illicit trade. And we’ll be testing out some of the latest anti-counterfeiting tech.

By attending live, registrants will be able to join the conversation with our experts from the comfort of their desks.

With previous speakers at Pharma Logistics IQ’s online summits including Roche, GSK and Johnson & Johnson, you can expect high-level insight and expertize.

To find out more information about how you can join us in September and view the full agenda click here

“Anti-counterfeiting and supply chain security is a growing issue for the pharmaceutical industry. In this summit, we want to share practical guidance and insight to help our community develop successful strategies to secure their products and protect patients.” said Natasha Taylor, Editor of Pharma Logistics IQ


About Pharma Logistics IQ:

Pharma Logistics IQ offers insight, resources and advice into many different aspects of the pharmaceutical supply chain, in online summits and webinars. The portal boasts over 125,000 online members and an impressive 2.2M+ global database. Pharma Logistics IQ is an online community designed to continue conversations beyond events with pharmaceutical professionals.

For more information contact: